Feasibility of Reducing Respiratory Drive Using the Through-flow System

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Health Network, Toronto

About this trial

Mechanical ventilation can lead to diaphragm and lung injury. During mechanical ventilation, the diaphragm could be completely rested or it could be overworked, either of which may cause diaphragm injury. Mechanical stress and strain applied by mechanical ventilation or by the patient's own respiratory muscles can also cause injury to the lungs. Diaphragm and lung injury are associated with increased morbidity and mortality. Throughflow is a novel system that can reduce dead space without the need to increase the tidal ventilation, reducing the ventilatory demands and respiratory drive.

Eligibility criteria

Qualifiers

PaO2/FiO2 less than or equal to 300 at time of screening

Oral endotracheal intubation with ETT 7.5 or 8.0 and on invasive mechanical ventilation

Bilateral airspace opacities on chest radiograph or chest CT scan

Disqualifiers

Contraindication to esophageal catheterization (upper gastrointestinal tract surgery within preceding 6 weeks, bleeding esophageal/gastric varices)

Intubation for traumatic brain injury or stroke

Intracranial hypertension (suspected or diagnosed by medical team)

Anticipated liberation from mechanical ventilation within 24 hours

Trial design

Treatments tested in this trial

  • Throughflow titration phase

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Health Network, Toronto

Lead sponsor

Unity Health Toronto

Collaborator